with autoimmune symptoms in the first months of life, starting with alopecia.
At the age of 8 months she presented first signs of autoimmune enteropathy (positive antienterocyte antibodies) for which she was treated with parenteral nutrition and tacrolimus. She was also diagnosed with celiac disease based on antibodies and histology (Marsh 3b/c). In the following years the enteropathy was controlled with gluten free diet and azathioprine.
At the age of 10 years she developed autoimmune hypothyroidism. At age 14 she received a liver transplant due to acute liver failure as a result of autoimmune hepatitis (ANA+, antismooth muscle intermediate).
After transplantation and under the immunosuppressive treatment of prednisone, tacrolimus and azathioprine, her autoimmune disease remained stable for several years.
However, recently, she had a relapse of her autoimmune enteropathy, making it necessary to increase prednisone and tacrolimus dosage and eventually to add Rapamycin.
The blood sampling for this study was performed prior to the addition of Rapamycin, unless otherwise indicated. 
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